[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "COVID risk factors and implications", "description": "COVID-19 risk assessment tool\n\nhttps://www.bma.org.uk/media/2768/bma-covid-19-risk-assessment-tool-july2020.pdf\n\nWork-based risk assessment\n\nModel does not incorporate other external factors\n\nHigh-risk household members\n\nThose at higher risk of mental health issues\n\nPregnancy \n\nThere is currently insufficient data to make any meaningful assessment about the risk of COVID-19 to either the mother or the unborn child\n\nIndeed the pandemic is not yet 9 months old\n\nUntil more information is available, we would recommend all people who are pregnant be regarded as high risk and offered the option to shield\n\nLow Risk   less than 3\n\nMedium Risk  3-5\n\nHigh Risk    equal to or more than 6\n\nAge \n\n less than 50   1 \n\nmore than 60   2 \n\nmore than 70   4 \n\nmore than 80   6 \n\nSex at Birth \n\nFemale  0 \n\nMale  1 \n\nEthnicity \n\nCaucasian    0 \n\nBlack African descent  2 \n\nIndian Asian descent  1 \n\nFilipino descent   1 \n\nOther (including Mixed race) 1 \n\nDiabetes\n\n(Type 1 or Type 2)   1 \n\n(Type 1 or Type 2)    2 \n(Complicated diabetes = presence of microvascular complications or HbA1c\u226564mmol/mol)\nObesity\n\nBMI\u226535kg/m2  1 \n\nCardiovascular disease \n\nAngina, previous MI, stroke \nor cardiac intervention   1\n\nHeart failure     2 \n\nPulmonary disease \n\nAsthma   1 \n\nNon-Asthma chronic pulmonary  2\n\nEither above requiring oral corticosteroids in previous year 1\n\nMalignant neoplasm \n\nActive malignancy 3 \n\nMalignancy in remission 1 \n\nRheumatological conditions \n\nActive treated conditions 2 \n\nImmunosuppressant therapy \n\nAny indication 2\n\nMore on comorbidities\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html#asthma\n\n\nEuropean CDC (weeks 42, ending 18th October)\n\nhttps://www.ecdc.europa.eu/en/covid-19/surveillance/weekly-surveillance-report\n\nSustained increase in cases over 2 weeks in 28 countries \n\nAt least 60 per 100 000\n\nAustria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Finland, France, Germany, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the UK\n\nSustained increase over 2 weeks in 16 countries in over 65s \n\nAt least 60 per 100 000\n\nAustria, Czechia, Denmark, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Romania, Slovenia, Spain and Sweden\n\nWeekly test positivity, at least 3% or had increased against the previous week, 19 countries\n\nAustria, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Iceland, Ireland, Italy, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden\n\nVaccine, early months of next year, Matt Hancock \n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-uk-latest-cases-deaths-airport-tests-schools/\n\nOxford, AstraZeneca, AZD1222\n\n30 million doses under UK manufacture\n\nRoll-out first half of 2021\n\nSome people vaccinated 2020\n\nImmune response similar across all age groups\n\nStrong immune response in elderly\n\nEncouraging to see immunogenicity responses were similar between older and younger adults (AZ)\n\nLower levels of side-effects in older adults\n\nElderly usually have a reduced immune response (e.g. influenza vaccine)\n\nAntibodies and T-cells\n\nBrazil, India, South Africa, UK, US\n\nMedicines and Healthcare products Regulatory Agency\n\nFood and Drug Administration\n\nIf you would like to donate to John's educational projects, please use the following link, thank you, https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=78GGHGLK5ZXAE", "link": "https://www.youtube.com/watch?v=Rpj9Ioudp7I", "date_published": "2020-10-27 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]